Announcements Trials
Browse Landscape

Phase

Phase 3 2Phase 2 2Phase NA 1

Status

Recruiting 27Active not recruiting 15Completed 7Not yet recruiting 5Terminated 3Withdrawn 2Unknown 1

Sponsor Class

OTHER 4NETWORK 1

Study Type

Interventional 5

Sponsor

Cancer Type

Genitourinary 5

Conditions

Prostatic Neoplasms 2Kidney Neoplasms 2Prostatic Neoplasms, Castration-Resistant 1High-Risk Localized Prostate Cancer 1Clear-cell metastatic renal cell carcinoma 1Carcinoma, Renal Cell 1Carcinoma 1

Interventions

Cisplatin 122Carboplatin 120Drug Therapy 104Bevacizumab 101Capecitabine 96Oxaliplatin 95Radiotherapy 92Gemcitabine 88Paclitaxel 87tislelizumab 84Cyclophosphamide 83Specimen Handling 80pembrolizumab 76toripalimab 66Magnetic Resonance Spectroscopy 63Fluorouracil 61sintilimab 58Injections 57anlotinib 51Docetaxel 51Surgical Procedures, Operative 48130-nm albumin-bound paclitaxel 48fludarabine 45Pemetrexed 43Standard of Care 42Biopsy 42venetoclax 41Irinotecan 41lenvatinib 40Leucovorin 40

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Not yet recruiting × Interventional × Pluvicto × Clear all
NCT07587814 2026-05-14

COCORIVO

Centre Henri Becquerel

Phase NA Not yet recruiting
100 enrolled
Genitourinary

Carcinoma, Prostatic Neoplasms, Prostatic Neoplasms, Castration-Resistant

NCT07550517 2026-04-24

PSMA-High: EBRT/ PSMA617/ ADT vs. EBRT/ ADT

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Phase 2 Not yet recruiting
60 enrolled
Genitourinary

High-Risk Localized Prostate Cancer

NCT06959433 2026-02-27

Lu-177 PSMA Treatment in Cell Renal Carcinoma

Ankara University

Phase 3 Not yet recruiting
20 enrolled
Genitourinary

Carcinoma, Renal Cell, Kidney Neoplasms

NCT07200830 2025-10-01

Testing Different Dosing Schedules of the Anti-cancer Drug, Lutetium 177Lu PSMA RLT and Its Effect on Patients With Advanced Prostate Cancer, RECIPROCAL Trial

Alliance for Clinical Trials in Oncology

Phase 3 Not yet recruiting
1,524 enrolled
Genitourinary

Prostatic Neoplasms

NCT06783348 2025-01-23

RENALUT

European Organisation for Research and Treatment of Cancer - EORTC

Phase 2 Not yet recruiting
48 enrolled
Genitourinary

Clear-cell metastatic renal cell carcinoma, Kidney Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡